 |
  |
| Author |
Message |
Yahoo News Bot
Joined: 01 Feb 2005
Posts: 33883
|
Posted:
Thu Feb 17, 2005 10:30 pm |
  |
Reuters - A U.S. advisory panel is set to
decide on Friday whether to recommend future sales of arthritis
drugs Vioxx, Celebrex and Bextra despite data linking the drugs
to higher risks of heart attacks.
Read more... |
|
|
|
 |
|
|
| |